DE69334183T2 - Von cyclodextrinen stabilisierter radiopharmazeutischer reagenzsatz - Google Patents

Von cyclodextrinen stabilisierter radiopharmazeutischer reagenzsatz Download PDF

Info

Publication number
DE69334183T2
DE69334183T2 DE69334183T DE69334183T DE69334183T2 DE 69334183 T2 DE69334183 T2 DE 69334183T2 DE 69334183 T DE69334183 T DE 69334183T DE 69334183 T DE69334183 T DE 69334183T DE 69334183 T2 DE69334183 T2 DE 69334183T2
Authority
DE
Germany
Prior art keywords
cyclodextrin
phosphine
kit
tris
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69334183T
Other languages
German (de)
English (en)
Other versions
DE69334183D1 (de
Inventor
Mark A. St. Louis DEROSCH
Edward A. Maryland Heights DEUTSCH
Mary Marmion Maryland Heights DYSZLEWSKI
Dennis L. Florissant NOSCO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of DE69334183D1 publication Critical patent/DE69334183D1/de
Publication of DE69334183T2 publication Critical patent/DE69334183T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE69334183T 1992-02-14 1993-02-09 Von cyclodextrinen stabilisierter radiopharmazeutischer reagenzsatz Expired - Fee Related DE69334183T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/836,644 US5300280A (en) 1992-02-14 1992-02-14 Stabilized radiopharmaceutical kits
US836644 1992-02-14
PCT/US1993/001196 WO1993015765A1 (en) 1992-02-14 1993-02-09 Stabilized radiopharmaceutical kits

Publications (2)

Publication Number Publication Date
DE69334183D1 DE69334183D1 (de) 2007-12-27
DE69334183T2 true DE69334183T2 (de) 2008-11-06

Family

ID=25272404

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69334183T Expired - Fee Related DE69334183T2 (de) 1992-02-14 1993-02-09 Von cyclodextrinen stabilisierter radiopharmazeutischer reagenzsatz

Country Status (15)

Country Link
US (2) US5300280A (enExample)
EP (2) EP1690552A3 (enExample)
JP (1) JPH07503960A (enExample)
AT (1) ATE378073T1 (enExample)
AU (1) AU3662493A (enExample)
BG (1) BG98971A (enExample)
CA (1) CA2129755C (enExample)
DE (1) DE69334183T2 (enExample)
FI (1) FI943724A0 (enExample)
HU (1) HUT74566A (enExample)
IL (1) IL104655A (enExample)
NO (1) NO942899L (enExample)
SK (1) SK96694A3 (enExample)
WO (1) WO1993015765A1 (enExample)
ZA (1) ZA93949B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
CA2158249A1 (en) * 1993-03-31 1994-10-13 James W. Brodack Radiopharmaceutical formulations having non-stannous reductants
US5911970A (en) * 1993-05-06 1999-06-15 Research Corporation Technologies, Inc. Methods for cancer imaging and therapy using benzamine compounds
US6517811B2 (en) 1993-05-06 2003-02-11 Research Corporation Technologies, Inc. Compounds for cancer imaging and therapy
US5993777A (en) * 1993-05-06 1999-11-30 Research Corporation Technologies, Inc. Benzamide compounds for cancer imaging and therapy
US5951964A (en) * 1993-06-04 1999-09-14 Diatide, Inc. Technetium-99m labeled peptides for imaging
FR2726765B1 (fr) * 1994-11-14 1996-12-20 Cis Bio Int Compositions radiopharmaceutiques comprenant un complexe d'inclusion d'une cyclodextrine et d'un acide gras radiohalogene
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
ES2243994T5 (es) 1996-04-19 2009-10-29 Grifols Inc. Procedimiento para la inactivacion virica de proteinas de la sangre liofilizadas.
IT1289660B1 (it) * 1996-10-03 1998-10-16 Sorin Biomedica Diagnost Spa Procedimento per la riduzione di composti ossigenati del renio o del tecnezio
WO1998029139A1 (fr) * 1996-12-25 1998-07-09 Gosudarstvenny Nauchny Tsentr Fiziko-Energetichesky Institut PREPARATION CONTENANT UN COMPOSE ORGANIQUE MARQUE A L'AIDE D'UN RADIONUCLEIDE $g(b)
US6905668B1 (en) * 1998-09-25 2005-06-14 Tokyo Gas Company Limited Diagnostic agents for pancreatic exocrine function
NZ337946A (en) * 1998-09-25 2001-11-30 Tokyo Gas Co Ltd C-13 labelled oligosaccharides and polysaccharides useful as diagnostic agents for pancreatic exocrine function
US6056941A (en) * 1999-07-28 2000-05-02 Bracco Research Usa Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
WO2006009894A1 (en) * 2004-06-17 2006-01-26 Anazaohealth Corporation Stabilized and lyophilized radiopharmaceutical agents for destroying tumors
US7229603B2 (en) * 2004-06-17 2007-06-12 Anazaohealth Corporation Stablilized and lyophilized radiopharmaceutical agents
US20070189965A1 (en) * 2004-06-17 2007-08-16 Kuperus John H Copper-complex isonitrile positron emission tomography (pet) imaging agent and method
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
US9321095B2 (en) 2010-06-30 2016-04-26 General Electric Company Apparatuses and methods for cutting porous substrates
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
GB202105950D0 (en) * 2021-04-26 2021-06-09 Ge Healthcare Ltd Analytical HPLC

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219270A (ja) * 1983-05-30 1984-12-10 Wako Pure Chem Ind Ltd テトラゾリウム塩を含有する溶液の安定化方法
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH064770B2 (ja) * 1984-07-31 1994-01-19 三菱電機株式会社 ジチオラト錯体−シクロデキストリン包接化合物の製造方法
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US4714605A (en) * 1986-10-14 1987-12-22 E. R. Squibb & Sons, Inc. Technetium-99m labeled dioxime complexes
US4871836A (en) * 1987-10-13 1989-10-03 E. R. Squibb & Sons, Inc. Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
CA1321192C (en) * 1988-04-20 1993-08-10 Abdul Majid Inclusion complexes of cyclodextrins by agglomeration
US5002754A (en) * 1988-06-15 1991-03-26 University Of Cincinnati Technetium (III/II) imaging agents
US5068227A (en) * 1989-01-18 1991-11-26 Cyclex, Inc. Cyclodextrins as carriers
US4917879A (en) * 1989-05-19 1990-04-17 University Of Cincinnati 99MTC(III) myocardial imaging agents that are effective in humans
US5080884A (en) * 1989-12-12 1992-01-14 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging
US5026913A (en) * 1989-12-12 1991-06-25 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol derivatives
US5183653A (en) * 1990-04-13 1993-02-02 E. R. Squibb & Sons, Inc. Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
US5112595A (en) * 1990-12-21 1992-05-12 Mallinckrodt Medical, Inc. 99MTC(III) myocardial imaging agents and method of use

Also Published As

Publication number Publication date
SK96694A3 (en) 1995-03-08
ZA93949B (en) 1993-12-07
CA2129755A1 (en) 1993-08-15
EP0625054A4 (en) 1996-04-17
JPH07503960A (ja) 1995-04-27
US5300280A (en) 1994-04-05
WO1993015765A1 (en) 1993-08-19
EP1690552A2 (en) 2006-08-16
NO942899L (no) 1994-08-04
AU3662493A (en) 1993-09-03
US6428768B1 (en) 2002-08-06
IL104655A0 (en) 1993-06-10
FI943724L (fi) 1994-08-12
DE69334183D1 (de) 2007-12-27
EP1690552A3 (en) 2008-07-02
BG98971A (bg) 1995-06-30
EP0625054A1 (en) 1994-11-23
EP0625054B1 (en) 2007-11-14
FI943724A7 (fi) 1994-08-12
FI943724A0 (fi) 1994-08-12
HUT74566A (en) 1997-01-28
NO942899D0 (enExample) 1994-08-04
ATE378073T1 (de) 2007-11-15
IL104655A (en) 1998-06-15
CA2129755C (en) 2006-01-03
HU9402349D0 (en) 1994-10-28

Similar Documents

Publication Publication Date Title
DE69334183T2 (de) Von cyclodextrinen stabilisierter radiopharmazeutischer reagenzsatz
DE69819721T2 (de) Zusammensetzung mit erhöhter lagerstabilität enthaltend cyclodextrin und wirkstoffe oder wirkstoff-vorstufen, die in wasserunlösliche komponenten zersetzt werden
EP0214647B1 (de) Inklusionskomplexe von 7-Isopropoxy-isoflavon mit Cyclodextrinen, Verfahren zu deren Herstellung und diese Inklusionskomplexe enthaltende pharmazeutische Präparate
DE69231457T2 (de) Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate
DE3650336T2 (de) Derivate von gamma-Cyclodextrin.
DE69030025T2 (de) Verfahren zur Markierung von Proteinen mit Technetium/Rhenium
DE69410118T2 (de) CYCLODEXTRINDERIVATE ZUR AUFLöSUNG VON HYDROPHOBEN, CHEMISCHEN VERBINDUNGEN WIE ARZNEIMITTELN; VERFAHREN ZU DEREN HERSTELLUNG
DE3789432T2 (de) Hochmolekulare Verbindung, bestehend aus einer Einheit einer zum Asialoglykoproteinakzeptor leitenden Verbindung und aus einer Einheit einer chelatformenden, an dieser chemisch gebundenen, Verbindung, und ihre Verwendung.
DE2948869C2 (enExample)
DE2920770A1 (de) Reduktionsmittel fuer technetium-99m und reduktionsverfahren unter bildung von mit technetium markierten stoffen
DE69212613T2 (de) Bakteriostatikum für radiopharmazeutische Mittel
DE69519463T2 (de) N-morpholino-n-nitrosaminoacetonitril-cyclodextrin-einschlussverbindungen
EP0532566B1 (de) 99m-Tc-CYCLOPENTADIENYLCARBONYL -KOMPLEXE, VERFAHREN ZU IHRER HERSTELLUNG SOWIE IHRE VERWENDUNG IN DER DIAGNOSTIK
DE10133394A1 (de) Flüssige Formulierung enthaltend Cetuximab
EP1515740A1 (de) Flüssige zubereitung enthaltend oligopeptide und verethertes cyclodextrin
DE60027436T2 (de) Zusammensetzung von radiopharmazeutischen Metallkomplexen in Silika-beschichteten Behältnissen
DE2708324A1 (de) Radioaktiv markiertes scanningmittel
DE69718406T2 (de) Strahlungsschutzmittel geignet zur Verwendung mit Radiopharmazeutika enthaltend reduzierbare aktive Inhaltsstoffe
DE69026387T2 (de) Reduktion der nichtzielspezifischen retention von immunokonjugaten und ihren metaboliten
DE69432268T2 (de) Verwendung von aminierten cyclodextrinen zum löslichmachen von als antiepileptika anzuwendenden dibenzazepinderivaten
DE69525647T2 (de) Inklusionskomplexe von radiohalogenierten fettsäuren in einer zyklodextrine
DE60004768T2 (de) Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
JP2715240B2 (ja) 放射性ヨウ素標識脂肪酸−シクロデキストリン複合体およびこれを含有するイメージング剤
DE2645571A1 (de) Stabiles, nicht-radioaktives traegermaterial, verfahren zu seiner herstellung und dieses traegermaterial enthaltende mittel
US6127530A (en) Method for the reduction of oxygenated compounds of rhenium or technetium

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee